Ping Zhang is Interim Chief Executive Officer of GYRE THERAPEUTICS, INC. (GYRE). The company reported total compensation of $4,096,623 for fiscal year 2025.
| Salary | $189,777 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $3,795,596 |
| Non-equity incentive plan | $100,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $11,250 |
| Total | $4,096,623 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure GYRE THERAPEUTICS, INC. filed April 27, 2026, accession 0001140361-26-017124.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Weiguo Ye | Chief Operating Officer | $5,023,749 |
| Ping Zhang this page | Interim Chief Executive Officer | $4,096,623 |
| Han Ying | Senior Vice President, Science and Former Chief Executive Officer | $353,315 |
| Ruoyu Chen | Chief Financial Officer | $285,583 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full GYRE THERAPEUTICS, INC. compensation brief.
Ping Zhang's compensation sits inside GYRE THERAPEUTICS, INC.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.